Here are three things to know:
1. The AMA supports authorizing the Secretary of the U.S. Department of Health and Human Services Reference Committee to expedite facility inspections and the review of drug applications, manufacturing changes and supplements that would help prevent or mitigate a drug shortage.
2. The AMA will push Congress and/or the FDA to require drug manufacturers to have a strategy to avert shortages.
3. According to an American Society of Anesthesiologists member survey, 98 percent of respondents regularly experience anesthesia drug shortages at their institutions, and 95 percent say the shortages adversely affect patient care.
More articles on supply chain:
Boston Scientific declines to comment on potential Stryker acquisition — 4 insights
Stryker seeks 12-year tax abatement for $92M expansion — 6 notes
German medical device manufacturer acquires Precision Medical Products — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.